Načítá se...
Contrasting Activities of Estrogen Receptor Beta Isoforms in Triple Negative Breast Cancer
PURPOSE. Triple negative breast cancer (TNBC), an aggressive subtype of breast cancer, lacks the three major receptors for predicting outcome or targeting therapy. Hence, our aim was to evaluate the potential of estrogen receptor beta (ERβ) as a possible endocrine therapy target in TNBC. METHODS. Th...
Uloženo v:
| Vydáno v: | Breast Cancer Res Treat |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867590/ https://ncbi.nlm.nih.gov/pubmed/33001337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05948-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|